Advertisement

Topics

Sophiris Bio Stock Plunges 38% on Mixed Prostate Cancer Trial Data http://dlvr.it/QtwNPz pic.twitter.com/4twH2AdMxw

02:19 EST 19 Dec 2018 | Biotechnology Twitter

Sophiris Bio Stock Plunges 38% on Mixed Prostate Cancer Trial Data http://dlvr.it/QtwNPz 

Original Article: Sophiris Bio Stock Plunges 38% on Mixed Prostate Cancer Trial Data http://dlvr.it/QtwNPz pic.twitter.com/4twH2AdMxw

NEXT ARTICLE

More From BioPortfolio on "Sophiris Bio Stock Plunges 38% on Mixed Prostate Cancer Trial Data http://dlvr.it/QtwNPz pic.twitter.com/4twH2AdMxw"

Advertisement
Quick Search
Advertisement
Advertisement